Herein we report the construction of a supramolecular cocrystal {Ti + Ti} through the combination of isolated {Ti} and {Ti} clusters. Moreover, the combined {Ti + Ti} complex presents better solar-driven photocatalytic dye degradation activity than the individual {Ti} and {Ti} compounds.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acs.inorgchem.6b02913 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Genotypic characterization of multi-drug-resistant Mycobacterium tuberculosis isolates in Myanmar.
J Infect Chemother
March 2016
Division of Bioresources, Hokkaido University Research Center for Zoonosis Control, Sapporo, Japan; Hokkaido University, The Global Station for Zoonosis Control, Sapparo, Japan. Electronic address:
The number of multi-drug-resistant tuberculosis (MDR-TB) cases is rising worldwide. As a countermeasure against this situation, the implementation of rapid molecular tests to identify MDR-TB would be effective. To develop such tests, information on the frequency and distribution of mutations associating with phenotypic drug resistance in Mycobacterium tuberculosis is required in each country.
View Article and Find Full Text PDFIsoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
J Antimicrob Chemother
October 2009
Section of Microbiology and Immunology, The Gade Institute, University of Bergen, N-5021 Bergen, Norway.
Objectives: To evaluate the frequency and nature of mutations in genes associated with resistance to rifampicin and isoniazid in Mycobacterium tuberculosis isolates collected from Yangon, Myanmar.
Methods: Ninety-six isoniazid-resistant M. tuberculosis isolates, including 29 multidrug-resistant isolates, were analysed for mutations in the rpoB, katG, inhA, oxyR and ahpC genes.
Predominance of Mycobacterium tuberculosis EAI and Beijing lineages in Yangon, Myanmar.
J Clin Microbiol
February 2009
Section for Microbiology and Immunology, The Gade Institute, University of Bergen and Haukeland University Hospital, Bergen, Norway.
Isolates of the Mycobacterium tuberculosis Beijing lineage are associated with high rates of transmission, hypervirulence and drug resistance. The Beijing lineage has been shown to dominate the tuberculosis (TB) epidemic in East Asia; however, the diversity and frequency of M. tuberculosis genotypes from Myanmar are unknown.
View Article and Find Full Text PDFStudy of drug resistant cases among new pulmonary tuberculosis patients attending a tuberculosis center, Yangon, Myanmar.
Southeast Asian J Trop Med Public Health
January 2007
Bacteriology Research Division, Department of Medical Research (Lower Myanmar), No 5 Ziwaka Road, Dagon PO, Yangon 11191, Myanmar.
A cross-sectional descriptive study was carried out at a tuberculosis center, Yangon, Myanmar from October 2003 to July 2004 to analyze the drug susceptibility of new sputum smear positive pulmonary tuberculosis patients. A total of 202 Mycobacterium tuberculosis isolates were tested for resistance to isoniazid, streptomycin, rifampicin and ethambutol. Resistance to at least one anti-tuberculosis drug was documented in 32 (15.
View Article and Find Full Text PDFDrug-resistant tuberculosis in Yangon, Myanmar.
Scand J Infect Dis
January 2006
Gade Institute, Section of Microbiology and Immunology, University of Bergen, Bergen, Norway.
The extent of drug resistant tuberculosis (TB) in the capital city of Myanmar, Yangon has not yet been reported. This study aimed to determine the proportion and pattern of drug resistance to first-line anti-TB drugs, among Mycobacterium tuberculosis complex isolates from sputum smear positive TB patients who attended National TB Programme Yangon centres in April-August and October-December 2002. Drug susceptibility was determined by the Mycobacteria Growth Indicator Tube manual system (Becton Dickinson, MD, USA).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!